[Federal Register Volume 69, Number 91 (Tuesday, May 11, 2004)]
[Notices]
[Page 26110]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-10600]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICE

Food and Drug Administration


Delegation of Authority

    Notice is hereby given that I have delegated to the Commissioner of 
Food and Drugs the authority under Public Law 107-108 (Best 
Pharmaceuticals for Children Act), as amended by section 3(b)(2) of 
Public Law 108-155 (Pediatric Research Equity Act of 2003), to charter, 
convene, consult, and appoint members to an advisory committee on 
pediatric therapeutics. This authority may be redelegated.
    The October 11, 2002, delegation of authority to you under Public 
Law 107-108 (Best Pharmaceuticals for Children Act) and Section 222 of 
the Public Health Service Act, as amended, (42 U.S.C. 217a), is 
superseded.
    This delegation is effective upon date of signature. In addition, I 
ratified and affirmed any actions taken by you or your subordinates, 
which involved the exercise of the authorities delegated herein, prior 
to the effective date of this delegation.

    Dated: April 30, 2004.
Tommy G. Thompson,
Secretary, Department of Health and Human Services.
[FR Doc. 04-10600 Filed 5-10-04; 8:45 am]
BILLING CODE 4160-01-M